Drug Shortage Report for SODIUM BICARBONATE INJECTION USP
Report ID | 182958 |
Drug Identification Number | 02516225 |
Brand name | SODIUM BICARBONATE INJECTION USP |
Common or Proper name | Sodium Bicarbonate Injection USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM BICARBONATE |
Strength(s) | 84MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10x50mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-02-01 |
Estimated end date | 2023-03-10 |
Actual end date | 2023-02-24 |
Shortage status | Resolved |
Updated date | 2023-02-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-02-25 | English | Compare |
v9 | 2023-02-24 | French | Compare |
v8 | 2023-02-24 | English | Compare |
v7 | 2023-02-24 | French | Compare |
v6 | 2023-02-24 | English | Compare |
v5 | 2023-02-02 | English | Compare |
v4 | 2023-02-01 | French | Compare |
v3 | 2023-02-01 | English | Compare |
v2 | 2023-02-01 | French | Compare |
v1 | 2023-02-01 | English | Compare |
Showing 1 to 10 of 10